Risk Assessment and Risk Management in the Pharmaceutical Industry: Clear and Simple (single user digital version)

Jan 2015
PDA Item Number
PDF Single user
Member Price
Nonmember Price
Government Price

Sale - 20% off!
Original Price US$255 PDA Member, US$319 Nonmember, US$160 Government
Sale prices are already displayed and will be reflected during checkout

Risk Assessment and Risk Management in the Pharmaceutical Industry: Clear and Simple, begins with history, definitions, how we think about risks and hazards, it gives overview of the risk management process and commonly used risk assessment methods and tools. It also explores the phases of the risk management process in detail and examines how the various tools can be applied in identifying hazards and evaluating their potential impact and affects. There are examples throughout the book that illustrate how the tools can be applied in "real life".

Click here to read a message from the author

Book written in June, 2006

Available to download. Prior to purchase please view the download instructions and Terms of Usage.
Format: PDF (1 file 3.61 MB)

Hardcover book is not available.

Table of Contents

Table of Contents:
Click here to download >>> Detailed Table of Contents


Chapter 1 - A Incomplete History of Risk Management (Click here to download >>>Chapter 1)
Chapter 2 - Hazards and risks: Concepts and definitions of important terms
Chapter 3 - Risks: Perceptions versus reality
Chapter 4 - Accident theory
Chapter 5 - An overview of the risk management process
Chapter 6 - Communication
Chapter 7 - An overview of risk assessment tools
Chapter 8 - Evaluation
Chapter 9 - Control
Chapter 10 - Monitoring
Chapter 11 - Risk related documentation and records
Chapter 12 - A detailed look at Hazard Analysis and Critical Control Points (HACCP)
Chapter 13 - A detailed look at Preliminary Risk Analysis (PRA)
Chapter 14 - A detailed look at Failure Modes, Effects and Criticality Analysis (FMECA)
Chapter 15 - A detailed look at Hazard Operations Analysis (HAZOPS)
Chapter 16 - A detailed look at Fault Tree Analysis (FTA)
Chapter 17 - A detailed look at Event Tree Analysis (ETA)
Chapter 18 - Auditing a risk management program
Chapter 19 - The organization and risk management
Appendices: Examples

About the Authors

About the Authors

James L. Vesper designs and develops instructional courses and workshops for the pharmaceutical and medical device industries. He established and is president of the firm, LearningPlus, Inc. and has had more than 25 years of experience in the pharmaceutical industry. Mr. Vesper worked eleven years at Eli Lilly and Company, Indianapolis. His last assignment there was Project Leader of GMP (Good Manufacturing Practice) Education and Instruction, establishing the department and its mission.

Since 1991, Mr. Vesper has been creating innovative instructional products for pharmaceutical firms using leader-led, video, and computer technologies as more effective and efficient delivery media. Working as consultants with a wide variety of clients, his firm creates integrated curricula for personnel and customized training courses targeted to particular needs. He provides workshops at various international technical and professional meetings. In 2001, he was awarded the PDA`s Agallaco Award for Excellence in Training. He is also the author of GMP in Practice, Fourth Edition, becomes one of the best sellers of PDA/DHI, co-published books.